PR100421

TAIZHOU, China, Oct. 20, 2023 /Xinhua-AsiaNet/--

On October 19, the 14th China (Taizhou) International Medical Expo commenced at

the China Medical City Convention Trade Center. Themed "Innovation Empowers the

Construction of a Large Health Industry Ecosystem", this edition of the Medical

Expo gathered nearly 130 industry experts from around the world. It featured

almost 600 renowned companies from 17 countries and regions, with 19

specialized event teams led by 8 academicians. Together, they collaborated to

contribute to the development of Taizhou's healthcare industry, empowering

Taizhou to establish itself as a global leader in the pharmaceutical and

healthcare sector.

In recent years, Taizhou has set its sights on the goal of achieving a

healthcare industry scale of 40 billion yuan by 2025, according to Taizhou

Medical High-Tech Zone (Gaogang District). Emulating top domestic and

international biopharmaceutical industry clusters, it has focused on

constructing a distinctive "3+2" industrial system, with a primary focus on the

three key pillars of biopharmaceuticals, new chemical drug formulations, in

vitro diagnostic reagents, and high-end medical equipment. Additionally, they

are committed to enhancing two distinctive industries -- special medical

formula foods and animal healthcare products. Presently, the China Medical City

has brought together over 1,300 healthcare companies, submitted applications

for more than 2,100 pharmaceutical innovations, and attracted over 4,300

high-level talents for entrepreneurship. Taizhou has also become the exclusive

pilot zone for the aggregation and development of the healthcare industry along

the Yangtze Economic Belt and a pilot zone for the development of new vaccines

and specific diagnostic reagents.

Taizhou, in collaboration with international organizations, multinational

enterprises, and academic institutions, is establishing research centers and

production bases, creating a city that leads in health innovation. Currently,

China Medical City has successfully established major innovation platforms such

as the National Technology Innovation Center for Veterinary Biological Products

(Taizhou), the Biopharmaceutical Innovation Research Institute of the Chinese

Academy of Sciences (CAS) Dalian Institute of Chemical Physics, and has

partnered with 12 renowned academic institutions to build 21 technology

platforms, including a Vaccine Engineering Center and a Drug Safety Evaluation

Center.

This Medical Expo features a significant presence of global healthcare industry

leaders and facilitated the convergence of numerous domestic and international

pharmaceutical innovation resources and top talents, creating a platform for

broader, deeper, and higher-level international exchange and collaboration

across various domains of the healthcare industry. Throughout the duration of

the Medical Expo, a total of 19 specialized events covering areas such as

biopharmaceuticals, medical devices, health services, and international

cooperation will invite participation from the public.

Source: Taizhou Medical High-Tech Zone (Gaogang District)